@inbook{0aff8b669e454414aa18c318b97e7a95,
title = "Restoration of Dystrophin Expression in Mdx-Derived Muscle Progenitor Cells Using CRISPR/Cas9 System and Homology-Directed Repair Technology",
abstract = "Duchenne muscular dystrophy (DMD) is a progressive myopathy caused by mutations in genes encoding dystrophin proteins that ultimately lead to depletion of myogenic progenitor cells (MPCs). Several approaches have been used to correctly express the dystrophin gene in induced pluripotent stem cells (iPSCs), including deletion of mutated exon 23 (ΔEx23) by clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated gene 9 (Cas9)-mediated gene editing technology. However, this approach is labor-intensive due to individual colony picking and genotyping to verify allelic modification. Here, we present a protocol to restore the function of the dystrophin gene by using homology-directed repair (HDR)-based CRISPR/Cas9 and inducing myogenic program of reprogrammed iPSCs from Mdx mice by inducible muscle-specific transcription factor MyoD.",
keywords = "CRISPR-Cas9-HDR gene editing, Duchenne muscular dystrophy, iPSC-derived myoprogenitors",
author = "Yue Jin and Yan Shen and Il-man Kim and Weintraub, {Neal L.} and Mark Hamrick and Yaoliang Tang",
note = "Funding Information: This work was supported by the American Heart Association (AHA) Transformational Project Award 18TPA34170104 and the National Institutes of Health (NIH) R01HL146481 (to I.K.); NIH R01HL134354 (to N.L.W. and Y.T.); as well as AHA Grant-in-Aid 16GRNT31430008 and NIH R01HL086555 (to Y.T.). Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.",
year = "2023",
doi = "10.1007/978-1-0716-2772-3_23",
language = "English (US)",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "455--464",
booktitle = "Methods in Molecular Biology",
}